Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
April 19, 2024 17:15 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and...
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
April 19, 2024 17:10 ET
|
ASLAN PHARMACEUTICALS LIMITED
SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative...
Junee Limited Announces Closing of $8 Million Initial Public Offering
April 19, 2024 16:30 ET
|
Junee Ltd
Hong Kong, April 19, 2024 (GLOBE NEWSWIRE) -- Junee Limited (the “Company” or “Junee”), a provider of interior design, fit-out and maintenance services in Hong Kong, today announced the closing of...
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
April 19, 2024 16:30 ET
|
Hepion Pharmaceuticals, Inc.
EDISON, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...
Arhaus Announces Showroom Opening in Greenwich, Connecticut
April 19, 2024 16:30 ET
|
Arhaus, Inc.
BOSTON HEIGHTS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) -- Arhaus, a leader in artisan-crafted furniture and home décor, announces the opening of its new 5,300 square-foot showroom in Greenwich,...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
April 19, 2024 16:30 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, the Company received a notification letter (the...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 19, 2024 16:30 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
Gulf Resources Announces Receipt of Nasdaq Non-Compliance Notice
April 19, 2024 16:30 ET
|
Gulf Resources, Inc.
SHOUGUANG, China, April 19, 2024 (GLOBE NEWSWIRE) -- Gulf Resources, Inc. (NASDAQ: GURE) (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical...
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
April 19, 2024 16:27 ET
|
Vaxxinity, Inc.
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of...
BCB Bancorp, Inc. Earns $5.9 Million in First Quarter 2024; Reports $0.32 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share
April 19, 2024 16:15 ET
|
BCB Bancorp, Inc.
BAYONNE, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported net income of $5.9...